Cell and Gene Therapy Insights Webinars

CELL AND GENE THERAPY INSIGHTS

To 1000L and beyond: streamlining AAV manufacturing with transfection complex stabilization

To 1000L and beyond: streamlining AAV manufacturing with transfection complex stabilization

Leisha Kopp, Mason Bonitz

Optimizing for faster quality control in cell therapies: leveraging rapid detection methods

Optimizing for faster quality control in cell therapies: leveraging rapid detection methods

Srinath Kashi Ranganath

Leveraging fluid dynamics characterization to accelerate cell therapy product development

Leveraging fluid dynamics characterization to accelerate cell therapy product development

Hamza Patel, Tom Heathman

AAV production and purification: key steps from design to GMP readiness

AAV production and purification: key steps from design to GMP readiness

Goutham Ganjam, Florian Leseigneur, Emily Jackson-Holmes

Non-viral GMP manufacturing for engineered cells at clinical and commercial scale

Non-viral GMP manufacturing for engineered cells at clinical and commercial scale

Leif Anderson, Chris Abraham

Combining CRISPR and transposon-based technologies for improved sdAb-based CAR-T therapies

Combining CRISPR and transposon-based technologies for improved sdAb-based CAR-T therapies

Begoña Diez Cabezas, Juan Roberto Rodriguez-Madoz

Optimizing plasmid DNA purification: strategies for reliable and expandable processes

Optimizing plasmid DNA purification: strategies for reliable and expandable processes

Christy Franco, Jasmina Puc

Making robust choices: evaluating materials in your AAV process

Making robust choices: evaluating materials in your AAV process

Michael Bodo, Birgit Rogell

Actionable insights for overcoming CMC challenges in TIL therapy: GRIT’s strategic approach

Actionable insights for overcoming CMC challenges in TIL therapy: GRIT’s strategic approach

1
2
>
>>

Case study: establishing a versatile and intensified lentiviral vector production platform with TFDF

Case study: establishing a versatile and intensified lentiviral vector production platform with TFDF

Find the EV needle in the haystack with Leprechaun

Find the EV needle in the haystack with Leprechaun

Navigating the transition from research to clinical-scale cell therapy manufacture

Navigating the transition from research to clinical-scale cell therapy manufacture

Steven Feldman, Johannes Fruehauf, Mary Ann Santos

A case study in faster, higher-quality pDNA manufacturing

A case study in faster, higher-quality pDNA manufacturing

Xiangming Gu, Lucas Smith

Spot-on, standard-free AAV titer and characterization with Stunner

Spot-on, standard-free AAV titer and characterization with Stunner

Flow with confidence: innovations that foster flexibility and scale in closed-system manufacturing

Flow with confidence: innovations that foster flexibility and scale in closed-system manufacturing

Safety assays for quality control of ATMPs: improved mycoplasma detection for cell-based biotherapeutics

Safety assays for quality control of ATMPs: improved mycoplasma detection for cell-based biotherapeutics

Jens Björkman, Andreas Hecker

Manufacturing Quality Control for Plasmid DNA Critical Starting Materials

Manufacturing Quality Control for Plasmid DNA Critical Starting Materials

A Frazer, L R. Salvitti, S Lovatt et al

Optimizing iPSC therapies: strategies for safe, cost-effective, and scalable manufacturing

Optimizing iPSC therapies: strategies for safe, cost-effective, and scalable manufacturing

K Bruce, K Bharti, I Barbaric et al

1
2
3
4
5
6
7
8
9
10
...
>
>>